Cargando…

In Silico Study to Identify New Antituberculosis Molecules from Natural Sources by Hierarchical Virtual Screening and Molecular Dynamics Simulations

Tuberculosis (TB) is an infection caused by Mycobacterium tuberculosis, responsible for 1.5 million documented deaths in 2016. The increase in reported cases of M. tuberculosis resistance to the main drugs show the need for the development of new and efficient drugs for better TB control. Based on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinto, Vinícius de S., Araújo, Janay S. C., Silva, Rai C., da Costa, Glauber V., Cruz, Jorddy N., De A. Neto, Moysés F., Campos, Joaquín M., Santos, Cleydson B. R., Leite, Franco H. A., Junior, Manoelito C. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469180/ https://www.ncbi.nlm.nih.gov/pubmed/30871010 http://dx.doi.org/10.3390/ph12010036

Ejemplares similares

Hierarchical Virtual Screening and Binding Free Energy Prediction of Potential Modulators of Aedes Aegypti Odorant-Binding Protein 1
por: Neto, Moysés F. A., et al.
Publicado: (2022)

Hierarchical Virtual Screening of Potential New Antibiotics from Polyoxygenated Dibenzofurans against Staphylococcus aureus Strains
por: Oliveira, Lana P. S., et al.
Publicado: (2023)

Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2
por: Bastos, Ruan S., et al.
Publicado: (2023)

In Silico Evaluation of Ibuprofen and Two Benzoylpropionic Acid Derivatives with Potential Anti-Inflammatory Activity
por: Bittencourt, José A. H. M., et al.
Publicado: (2019)

Identification of New Inhibitors with Potential Antitumor Activity from Polypeptide Structures via Hierarchical Virtual Screening
por: Ferreira, Elenilze F. B., et al.
Publicado: (2019)

Hierarchical Virtual Screening of Potential Insectides Inhibitors of Acetylcholinesterase and Juvenile Hormone from Temephos
por: V. da Costa, Glauber, et al.
Publicado: (2019)

Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies
por: de Almeida, Raquel B. M., et al.
Publicado: (2023)

Identification of Novel Chemical Entities for Adenosine Receptor Type 2A Using Molecular Modeling Approaches
por: dos Santos, Kelton L. B., et al.
Publicado: (2020)

Identification of Novel Protein Kinase Receptor Type 2 Inhibitors Using Pharmacophore and Structure-Based Virtual Screening
por: Cruz, Josiane V., et al.
Publicado: (2018)

Identification of Potential Insect Growth Inhibitor against Aedes aegypti: A Bioinformatics Approach
por: Da Costa, Glauber V., et al.
Publicado: (2022)

Identification of Potential Inhibitors from Pyriproxyfen with Insecticidal Activity by Virtual Screening
por: da Silva Ramos, Ryan, et al.
Publicado: (2019)

In silico study of phytochemicals contained in Brucea javanica in inhibiting the InhA enzyme as antituberculosis
por: Sulistyowaty, Melanny Ika, et al.
Publicado: (2023)

Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach
por: Leão, Rozires P., et al.
Publicado: (2020)

Risk factors associated with adverse reactions to antituberculosis drugs
por: Resende, Laíse Soares Oliveira, et al.
Publicado: (2015)

Variation in the Chemical Composition of Endemic Specimens of Hedychium coronarium J. Koenig from the Amazon and In Silico Investigation of the ADME/Tox Properties of the Major Compounds
por: Cruz, Jorddy Neves, et al.
Publicado: (2023)

Acquired Resistance to Antituberculosis Drugs
por: Aung, Htin Lin, et al.
Publicado: (2018)

Hierarchical Virtual Screening Based on Rocaglamide Derivatives to Discover New Potential Anti-Skin Cancer Agents
por: dos Santos, Igor V.F., et al.
Publicado: (2022)

Factors affecting successful antituberculosis treatment: a single-center experience
por: Gonçalves, Marcella Cardoso, et al.
Publicado: (2023)

Similarity-Based Virtual Screening to Find Antituberculosis Agents Based on Novel Scaffolds: Design, Syntheses and Pharmacological Assays
por: García-García, Ángela, et al.
Publicado: (2022)

Analgesic Activity of 5-Acetamido-2-Hydroxy Benzoic Acid Derivatives and an In-Vivo and In-Silico Analysis of Their Target Interactions
por: Santos, Cleydson B. R., et al.
Publicado: (2023)

Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis l,d-transpeptidase 2
por: Billones, Junie B, et al.
Publicado: (2016)

Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches
por: Araújo, Pedro H. F., et al.
Publicado: (2020)

Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach
por: Silva, Luciane B., et al.
Publicado: (2023)

Antituberculosis drug-induced hepatotoxicity in children
por: Donald, Peter R
Publicado: (2011)

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
por: Salinger, David H., et al.
Publicado: (2019)

Diagnosis of Hypersensitivity Induced by Antituberculosis Drugs
por: Wu, Yuqing, et al.
Publicado: (2021)

Barriers to Initiation of Antiretrovirals during Antituberculosis Therapy in Africa
por: Pepper, Dominique J., et al.
Publicado: (2011)

Syntheses and evaluation of multicaulin and miltirone-like compounds as antituberculosis agents
por: Burmaoğlu, Serdar, et al.
Publicado: (2017)

Evaluation of antiplasmodial activity in silico and in vitro of N-acylhydrazone derivatives
por: Oliveira, Fernanda A., et al.
Publicado: (2022)

Association between serum selenium level and conversion of bacteriological tests during antituberculosis treatment
por: de Moraes, Milena Lima, et al.
Publicado: (2014)

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique,
por: Pires, Germano Manuel, et al.
Publicado: (2014)

The impact of immune disturbances on the failure of antituberculosis treatment
por: LESNIC, EVELINA, et al.
Publicado: (2016)

Empyema Necessitans due to Interruption of Antituberculosis Treatment
por: Benaragama, H. N., et al.
Publicado: (2019)

In silico identification of novel chemical compounds with antituberculosis activity for the inhibition of InhA and EthR proteins from Mycobacterium tuberculosis
por: Halder, Sajal Kumar, et al.
Publicado: (2021)

Investigating the Antituberculosis Activity of Selected Commercial Essential Oils and Identification of Active Constituents Using a Biochemometrics Approach and In Silico Modeling
por: Boussamba-Digombou, Katyna J., et al.
Publicado: (2022)

Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination
por: Koeken, Valerie A. C. M., et al.
Publicado: (2022)

Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges
por: Rangel, Maria Adriana, et al.
Publicado: (2017)

Pharmacological Characteristics of the Hydroethanolic Extract of Acmella oleracea (L) R. K. Jansen Flowers: ADME/Tox In Silico and In Vivo Antihypertensive and Chronic Toxicity Evaluation
por: Rodrigues, Emanuelle T., et al.
Publicado: (2023)

Site-Specific Modification of the Anticancer and Antituberculosis Polyether Salinomycin by Biosynthetic Engineering
por: Luhavaya, Hanna, et al.
Publicado: (2014)

Short and Efficient Synthesis of the Antituberculosis Agent Pretomanid from (R)-Glycidol
por: Lucas, Tobias, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_brv16s50kmb5foel2qg5u3iruo